Rapid bacterial identification, resistance, virulence and type profiling using selected reaction monitoring mass spectrometry

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Charretier, Yannick ^a,b,f   Dauwalder, Olivier ^c,d   Franceschi, Christine ^e   Degout Charmette, Elodie ^a   Zambardi, Gilles ^e   Cecchini, Tiphaine ^a   Bardet, Chloe ^a,g   Lacoux, Xavier ^e   Dufour, Philippe ^e,g   Veron, Laurent ^a   Rostaing, Hervé ^e   Lanet, Veronique ^a   Fortin, Tanguy ^a   Beaulieu, Corinne ^a   Perrot, Nadine ^e   Dechaume, Dominique ^e   Pons, Sylvie ^a   Girard, Victoria ^e   Salvador, Arnaud ^b   Durand, Géraldine ^e   Mallard, Frédéric ^e   Theretz, Alain ^a   Broyer, Patrick ^e   Chatellier, Sonia ^e   Gervasi, Gaspard ^a   Van Nuenen, Marc ^e   Ann Roitsch, Carolyn ^e   Van Belkum, Alex ^e   Lemoine, Jérôme ^b   Vandenesch, François ^c,d   Charrier, Jean Philippe ^a   more..

^a Innovation Unit   (France)

^b UNIVERSITÉ DE LYON   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^e BIOMÉRIEUX   (France)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g Technology Research Department Innovation Unit Marcy l'Etoile BioMérieux SA ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIUM; BACTERIUM IDENTIFICATION; CLASSIFICATION; DRUG EFFECTS; GENETICS; HUMAN; MASS SPECTROMETRY; MICROBIOLOGY; PATHOGENICITY; PROCEDURES; REPRODUCIBILITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VIRULENCE;

BACTERIA; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; HUMANS; MASS SPECTROMETRY; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 84941299633     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13944     Document Type: Article

References (46)

1. DAmato, R. F., Holmes, B. & Bottone, E. J. The systems approach to diagnostic microbiology. Crit Rev. Microbiol. 9, 1-44 (1981).
2. Menozzi, M. G., et al. Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria. J. Clin. Microbiol. 44, 4085-4094 (2006).
3. Anhalt, J. P. & Fenselau, C. Identification of bacteria using mass spectrometry. Anal. Chem. 47, 219-225 (1975).
4. Welker, M. Proteomics for routine identification of microorganisms. Proteomics. 11, 3143-3153 (2011).
5. Van Belkum, A. & Dunne, W. M., Jr. Next-generation antimicrobial susceptibility testing. J. Clin. Microbiol. 51, 2018-2024 (2013).
6. Perez, K. K., et al. Integrating Rapid Pathogen Identification and Antimicrobial Stewardship Significantly Decreases Hospital Costs. Arch. Pathol. Lab Med. 137, 1247-1254 (2012).
7. Machen, A., Drake, T. & Wang, Y. F. Same day identification and full panel antimicrobial susceptibility testing of bacteria from positive blood culture bottles made possible by a combined lysis-filtration method with MALDI-TOF VITEK mass spectrometry and the VITEK2 system. PLoS. One. 9, e87870 (2014).
8. Jung, J. S., et al. Rapid detection of antibiotic resistance based on mass spectrometry and stable isotopes. Eur. J. Clin. Microbiol. Infect. Dis. 33, 949-955 (2014).
9. Jung, J. S., et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of beta-lactam resistance in Enterobacteriaceae derived from blood cultures. J. Clin. Microbiol. 52, 924-930 (2014).
10. Hooff, G. P., et al. Characterization of beta-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J. Proteome. Res. 11, 79-84 (2012).
11. Wisplinghoff, H., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309-317 (2004).
12. Oliveira, D. C., Tomasz, A. & De Lencastre, H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2, 180-189 (2002).
13. Ito, T., et al. Guidelines for reporting novel mecA gene homologues. Antimicrob. Agents Chemother. 56, 4997-4999 (2012).
14. Lindsay, J. A. Staphylococcus aureus genomics and the impact of horizontal gene transfer. Int. J. Med. Microbiol. 304, 103-109 (2014).
15. Gillet, Y., et al. Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases. Int. J. Antimicrob. Agents 38, 457-464 (2011).
16. Lappin, E. & Ferguson, A. J. Gram-positive toxic shock syndromes. Lancet Infect. Dis. 9, 281-290 (2009).
17. Lina, G., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29, 1128-1132 (1999).
18. Gillet, Y., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359, 753-759 (2002).
19. Vandenesch, F., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9, 978-984 (2003).
20. Picotti, P., Bodenmiller, B. & Aebersold, R. Proteomics meets the scientific method. Nat. Methods 10, 24-27 (2013).
21. Bereman, M. S., Maclean, B., Tomazela, D. M., Liebler, D. C. & Maccoss, M. J. The development of selected reaction monitoring methods for targeted proteomics via empirical refinement. Proteomics. 12, 1134-1141 (2012).
22. Kirkpatrick, D. S., Gerber, S. A. & Gygi, S. P. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods 35, 265-273 (2005).
23. Monecke, S., Jatzwauk, L., Weber, S., Slickers, P. & Ehricht, R. DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from Eastern Saxony. Clin. Microbiol. Infect. 14, 534-545 (2008).
24. Hallin, M., Friedrich, A. W. & Struelens, M. J. spa typing for epidemiological surveillance of Staphylococcus aureus. Methods Mol. Biol. 551, 189-202 (2009).
25. Perez, K. K., et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch. Pathol. Lab Med. 137, 1247-1254 (2013).
26. Wimmer, J. L., et al. Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system. J. Clin. Microbiol. 50, 2452-2454 (2012).
27. Klein, S., et al. Integration of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in blood culture diagnostics: a fast and effective approach. J. Med. Microbiol. 61, 323-331 (2012).
28. Anderson, N. L., et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J. Proteome. Res. 3, 235-244 (2004).
29. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W. & Gygi, S. P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 100, 6940-6945 (2003).
30. Beynon, R. J., Doherty, M. K., Pratt, J. M. & Gaskell, S. J. Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides. Nat. Methods 2, 587-589 (2005).
31. Dupuis, A., Hennekinne, J. A., Garin, J. & Brun, V. Protein Standard Absolute Quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks. Proteomics. 8, 4633-4636 (2008).
32. Abbatiello, S. E., et al. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Mol. Cell Proteomics. 12, 2623-2639 (2013).
33. Surinova, S., et al. Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies. Nat. Protoc. 8, 1602-1619 (2013).
34. Cox, J., et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteomics. 13, 2513-2526 (2014).
35. Worboys, J. D., Sinclair, J., Yuan, Y. & Jorgensen, C. Systematic evaluation of quantotypic peptides for targeted analysis of the human kinome. Nat. Methods 11, 1041-1044 (2014).
36. Mohammed, Y., Percy, A. J., Chambers, A. G. & Borchers, C. H. Qualis-SIS: Automated Standard Curve Generation and Quality Assessment for Multiplexed Targeted Quantitative Proteomic Experiments with Labeled Standards. J. Proteome. Res. 14, 1137-1146 (2015).
37. Charretier, Y., et al. Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Front Microbiol. 6, 81 (2015).
38. Lemoine, J., et al. The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation. Expert. Rev. Mol. Diagn. 12, 333-342 (2012).
39. Fortin, T., et al. Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol. Cell Proteomics. 8, 1006-1015 (2009).
40. Kumar, A., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 34, 1589-1596 (2006).
41. Francois, P., et al. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J. Clin. Microbiol. 41, 254-260 (2003).
42. Francois, P., et al. A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J. Clin. Microbiol. 42, 3309-3312 (2004).
43. Francois, P., et al. Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg. Infect. Dis. 14, 304-307 (2008).
44. Harmsen, D., et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41, 5442-5448 (2003).
45. Monecke, S., Luedicke, C., Slickers, P. & Ehricht, R. Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur. J. Clin. Microbiol. Infect. Dis. 28, 1159-1165 (2009).
46. Enright, M. C., Day, N. P., Davies, C. E., Peacock, S. J. & Spratt, B. G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38, 1008-1015 (2000).